We are live on ! Find out more
HP

Hikari Power Portfolio holdings

AUM $855M
1-Year Est. Return 14.24%
This Fund
S&P 500
This Quarter Est. Return
-0.65%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$997M
AUM Growth
-$16.6M
Cap. Flow
-$4.02M
Cap. Flow %
-0.4%
Top 10 Hldgs %
68.44%
Holding
70
New
–
Increased
15
Reduced
2
Closed
2

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$1.46M
2
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
+$1.41M
3
MO icon
Altria Group
MO
+$907K
4
ABBV icon
AbbVie
ABBV
+$668K
5
VHT icon
Vanguard Health Care ETF
VHT
+$544K

Top Sells

Rank Stock Value
1
WFC icon
Wells Fargo
WFC
+$11.1M
2
NVCR icon
NovoCure
NVCR
+$377K
3
BABA icon
Alibaba
BABA
+$247K
4
BNY
Bank of New York Mellon
BNY
+$85.8K

Sector Composition

Rank Sector Weight
1 Financials 45.56%
2 Healthcare 19.85%
3 Industrials 6.7%
4 Materials 6.24%
5 Energy 4.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UNP icon
51
Union Pacific
UNP
$174B
$800K 0.08%
4,080
– –
PRU icon
52
Prudential Financial
PRU
$42.2B
$668K 0.07%
6,350
– –
MET icon
53
MetLife
MET
$61.5B
$653K 0.07%
10,580
– –
PH icon
54
Parker-Hannifin
PH
$134B
$629K 0.06%
2,250
– –
VEEV icon
55
Veeva Systems
VEEV
$38.4B
$576K 0.06%
2,000
– –
VZ icon
56
Verizon
VZ
$196B
$508K 0.05%
9,400
– –
ASHR icon
57
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.58B
$446K 0.04%
11,700
– –
ECL icon
58
Ecolab
ECL
$79.8B
$438K 0.04%
2,100
– –
ALDX icon
59
Aldeyra Therapeutics
ALDX
$91.1M
$176K 0.02%
20,020
– –
AKTX
60
Akari Therapeutics
AKTX
$13.5M
$146K 0.01%
112
– –
ALPN
61
DELISTED
Alpine Immune Sciences Inc
ALPN
$111K 0.01%
10,445
– –
CRVS icon
62
Corvus Pharmaceuticals
CRVS
$1.24B
$97K 0.01%
19,959
– –
BDSI
63
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$90K 0.01%
25,000
– –
AMRN
64
Amarin Corp
AMRN
$296M
$77K 0.01%
750
– –
ADMA icon
65
ADMA Biologics
ADMA
$2.22B
$34K ﹤0.01%
30,075
– –
BABA icon
66
Alibaba
BABA
$306B
– –
-1,090
Closed -$247K
NVCR icon
67
NovoCure
NVCR
$2.06B
– –
-1,700
Closed -$377K
1 2
3

Similar funds

QIM
Quest Investment Management Lake Oswego, Oregon $857M AUM 21.67% 1-Year Est. Return
NOCM
Night Owl Capital Management Greenwich, Connecticut $858M AUM 31.41% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
EPIMS
Evelyn Partners Investment Management Services London $850M AUM 20.89% 1-Year Est. Return
BCM
Benchstone Capital Management New York $860M AUM 32.46% 1-Year Est. Return
PCM
Parsifal Capital Management Greenwich, Connecticut $849M AUM 28.52% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Hikari Power's Q3 2021 Portfolio in Review

As of Q3 2021, Hikari Power held 70 positions worth $997M, down 1.6% from $1.01B the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 2.9%. Hikari Power opened no new positions and exited 2, leaving the 70-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 46% of assets, down from 46% a quarter earlier, followed by Healthcare and Industrials.

  • Hikari Power added most to ExxonMobil in Q3 2021, an estimated $1.46M increase.
  • Hikari Power's biggest Q3 2021 reduction was Wells Fargo, cutting an estimated $11.1M.
  • Hikari Power fully exited NovoCure in Q3 2021, selling an estimated $377K.
  • Hikari Power's ten largest holdings make up 68% of its $997M portfolio in Q3 2021.
  • Hikari Power opened 0 new positions and closed 2 in Q3 2021.
  • Hikari Power's portfolio value fell 1.6% quarter-over-quarter to $997M.

Based on Hikari Power's 13F filing for Q3 2021, filed 13 Oct 2021.